Hutchin Hill Capital’s Abiomed Inc ABMD Stock Holding History

Hutchin Hill Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-19,600	Closed	-$1.77M	–	803
2015 Q4	$1.77M	Buy	+19,600	New	+$1.66M	0.04%	324
2015 Q3	–	Sell	-13,400	Closed	-$881K	–	794
2015 Q2	$881K	Buy	13,400 +9,000	+205%	+$598K	0.02%	495
2015 Q1	$315K	Buy	+4,400	New	+$239K	0.01%	590

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hutchin Hill Capital's ABMD Position: Q1 2016 in Review

Hutchin Hill Capital sold out of Abiomed Inc (ABMD) in Q1 2016, closing a stake of 19,600 shares — an estimated $1.77M sold.

Hutchin Hill Capital first reported a position in ABMD in Q1 2015 and held it in 3 quarters. The position peaked at $1.77M in Q4 2015. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

Hutchin Hill Capital reported no remaining Abiomed Inc position as of Q1 2016 after selling out during the quarter.
Hutchin Hill Capital sold 19,600 Abiomed Inc shares in Q1 2016, an estimated $1.77M.
Hutchin Hill Capital first reported a position in Abiomed Inc in Q1 2015 and held it in 3 quarters.
Hutchin Hill Capital's Abiomed Inc position peaked at $1.77M in Q4 2015.
274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Hutchin Hill Capital's 13F filing for Q1 2016, filed 16 May 2016.